Hagop Youssoufian, MD
Enriched profileChief Medical Advisor, Kojin Therapeutics; Founder and Principal, Youssoufian Consulting, LLC · Youssoufian Consulting
Hagop Youssoufian is Chief Medical Advisor, Kojin Therapeutics; Founder and Principal, Youssoufian Consulting, LLC at Youssoufian Consulting. ClinicalTrials.gov lists 25 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 2 Sept 2026
Hagop Youssoufian, MD, is Chief Medical Advisor, Kojin Therapeutics at Youssoufian Consulting, LLC (Founder/Principal) and Kojin Therapeutics (Chief Medical Advisor). The public record shows 295 publications with 17,129 citations (h-index 51), centered on Leukemia (AML/ALL/CML/CLL), Pancreatic Cancer, Colorectal Cancer. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 25 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:
- Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Sponsor: Treos Bio Limited
Industry payments
Updated 2 Sept 2026
1 company reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20242 payments$78,000openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
Clinical Cancer Research
2016 - PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
Journal of Nuclear Medicine
2015
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/hagop-youssoufian-04b4896
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/hagop-youssoufian
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
oncodaily.com/career/163442
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - LinkedIn
LinkedIn: linkedin.com/in/hagop-youssoufian (Biotech Consultant, Adjunct Professor)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
Twitter/X: @hyoussoufian
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- Internal medicine training
Cleveland Clinic and Johns Hopkins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Fellowship
Clinical Genetics, Johns Hopkins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Fellowship
Hematology-Oncology, Massachusetts General Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Board Certified
Internal Medicine and Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →findatopdoc.com ↗
Editorial & leadership roles
journal and society appointments- Adjunct Professor of Medicine
Brown University (appointment renewed for 5-year term, announced March 2026); engages with hematology-oncology division and cancer center fellows/faculty on drug-development perspectives
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor of Medicine
Brown University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
- Guest
Biotech2050 Podcast, discussed genetics-informed precision medicine drug development
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center